newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics to Report First Quarter 2022 Financial Results on May 17

TEL AVIV, Israel and NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a late-clinical stage biotechnology company focused on developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune or in